The how and why of chronic pain states and the what of new analgesia therapies
- 1 August 1998
- journal article
- Published by Elsevier in Trends in Neurosciences
- Vol. 21 (8) , 315-317
- https://doi.org/10.1016/s0166-2236(98)01291-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibresPublished by Elsevier ,1998
- Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1receptor antagonistBritish Journal of Pharmacology, 1998
- Inhibition of Hyperalgesia by Ablation of Lamina I Spinal Neurons Expressing the Substance P ReceptorScience, 1997
- Gabapentin (neurontin) and S‐(+)‐3‐isobutylgaba represent a novel class of selective antihyperalgesic agentsBritish Journal of Pharmacology, 1997
- Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin testNeuroReport, 1997
- Vanilloid receptors: new insights enhance potential as a therapeutic targetPain, 1996
- Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbilsPain, 1996
- Receptor Endocytosis and Dendrite Reshaping in Spinal Neurons After Somatosensory StimulationScience, 1995
- An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the ratPain, 1992
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988